New Information 
If new information about Interleukin- 2 , Interleukin- 4 , or TIL's becomes 
known to the investigators during the course of the study which may affect your 
willingness to continue to participate, it will be provided to you. 
Cost and Payments 
You will be expected to provide insurance coverage for payments for all 
routine and subsequent care, and for any sickness or problems that may arise out 
of the nature of your disease. You will be charged as for routine treatments for 
all outpatient visits, hospitalization, routine blood samples and other tests 
performed to evaluate the course of your tumor prior to and following this 
program of therapy. IL-2. IL-4. TIL^s and the gene marking procedure will be 
supplied free of charge. This study is monitored by the National Cancer 
Institute . 
Confidentiality 
You understand that any information obtained about you from this research, 
including answers to questionnaires, history, laboratory data, findings on 
physical examination, biopsy, surgery, or audio or videotapes will be kept 
confidential. You do understand that your research records, like hospital 
records, may be subpoenaed by court order. It has been explained to you that 
your identity will not be revealed in any description or publication of this 
research. Therefore, you consent to such publication for scientific purposes. 
Scientifically trained and properly authorized employees of the drug (IL-2 
or IL-4) manufacturers, of the Food and Drug Administration, the National Cancer 
Institute and the Pittsburgh Cancer Institute may inspect the relevant records. 
Right to Withdraw 
You understand that you are free to refuse to participate in this study or 
to withdraw at any time and that your decision will not adversely affect your 
care at this institution or cause a loss of benefits to which you might otherwise 
be entitled. You also understand that investigator (s) may require that you 
withdraw from the study but that we would strongly encourage yu to continue to 
participate in long term follow-up so. that this information from the 
administration of gene marked TIL's mieht be obtained. 
Compensation for Illness or Injury 
You understand that in the event of a physical injury or illness resulting 
from the research procedure no monetary compensation will be made, but any 
immediate emergency medical treatment which may be necessary will be provided. 
You can call the investigator to obtain information about treatment if it is 
needed. 
/P5 
Recombinant DNA Research, Volume 14 
[861] 
